ESSO-BASO Webinar on The Evolving Concept of Neoadjuvant Therapy and Advanced Surgery for Pancreatic Cancer
31 May, 2023 - Preview
Time: 6pm to 7.15pm CET
Aims of the webinar
The webinar will cover the latest evidence and indications for neoadjuvant treatment in different stages pancreatic cancer and the recent advances in surgical resection of locally advanced disease.
- Update on the evidence and recommendations for use of neoadjuvant treatment in primary resectable pancreatic cancer.
- How to select the most appropriate neoadjuvant regimen and monitor the effect of neoadjuvant treatment in patients with borderline and locally advanced pancreatic cancer.
- To know the indications and technical possibilities for surgical resection of borderline and locally advanced pancreatic cancer.
Zaed Hamady, University Hospital Southampton NHS Foundation Trust, Southampton, UK
Sven Mieog, Leiden University Medical Center, Leiden,NL
Carlos Carvalho, Champalimaud Foundation, Lisbon, PT
Bas Groot Koerkamp, Erasmus University Medical Center, Rotterdam, NL
Elena Rangelova, Sahlgrenska University Hospital, Gothenburg, SE
18.00-18.20: The evolving concept of neoadjuvant treatment in resectable pancreatic cancer – is it time?, B G. Koerkamp
18.20-18.40: Borderline and locally advanced pancreatic cancer: Choice of neoadjuvant treatment, patients, and evaluating treatment response, C. Carvalho
18.40-19.00: Patient selection and principles of resection for borderline and locally advanced pancreatic cancer, E. Rangelova
- HPB surgeons
- HPB fellows
- General surgeons
- Surgical trainees
- Medical oncologists with focus on pancreatic cancer
Registration is free to all.
Please click here to register.